Source: Eur Respir J 2004; 23: 901-905



Rating:

Share or cite this content

Citations should be made in the following way:
Lund M.B., Brinch L., Kongerud J., Boe J.. Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide. Eur Respir J 2004; 23: 901-905

Member's Comments

No comment yet.

Related content which might interest you: Lung transplantation after allogeneic bone-marrow transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 634s Year: 2005 Telespirometry for home monitoring of pulmonary function in patients after allogeneic bone marrow transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 242s Year: 2003 Pulmonary function in very long-term survivors after allogeneic stem cell transplantation (aSCT) Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions Year: 2018 Pulmonary dysfunction after bone marrow transplantation (BMT) for thalassemia major: long-term results Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004 Lung transplantation after bone marrow transplantationin paediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 725s Year: 2006 Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Pulmonary hypertension after bone marrow transplantation in children Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019 Year: 2019 Airway distensibility with lung inflation following allogeneic haematopoietic stem-cell transplantation (HSCT) Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Lung transplantation after allogeneic stem cell transplantation: a pan-European experience Source: Eur Respir J, 51 (2) 1701330; 10.1183/13993003.01330-2017 Year: 2018 Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Pulmonary involvement in haematological disorders and bone marrow transplant recipients Source: Eur Respir Monogr 2019; 86: 333-358 Year: 2019 Bronchiolar and pulmonary complications in recipients of bone marrow/stem cell transplantation Source: Annual Congress 2010 - The lung in haematological disorders Year: 2010 Pulmonary complications in bone marrow transplant recipients Source: Annual Congress 2010 - Managing pulmonary complications in the immunocompomised host Year: 2010 Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study Source: Eur Respir J 2005; 25: 490-493 Year: 2005 Monitoring of lung function and airways inflammation after bone marrow transplantation Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Beneficial effects of autologous bone marrow mononuclear cell transplantation via the trachea against elastase-induced emphysema in rabbits Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008